“Pemphigus, an autoimmune disease mediated by B cells and which causes painful blisters and sores on the skin and mucous membranes, is a rare chronic autoimmune condition that can be fatal if not treated.”
“Treatment for pemphigus, most commonly through an oral medication, was often slow and would not result in complete remission.”
“Now, new research from a team in the Perelman School of Medicineshows that a lymphoma-dose regimen of rituximab, a medication regularly used to treat lymphoma and rheumatoid arthritis, is more likely to put patients with pemphigus into complete remission as compared to a rheumatoid arthritis (RA) regimen of the same medication.”
View the whole story here: https://penntoday.upenn.edu/news/complete-remission-within-reach-rare-autoimmune-disease